|
⚲
|
| Keyboard |
| MPM BioVentures IV Strategic Fund LP
✚
|
|
|---|---|
| CIK # | 0001577429 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001577429] | |
| 4 | [0001577429] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Syndax Pharmaceuticals Inc SNDX
Series C-1 Preferred Stock · derivative
|
2016-03-08 | Conversion | 312,085 | ||
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2016-03-08 | Conversion | 312,085 | ||
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2016-03-08 | Conversion | 1,138,210 | ||
|
Syndax Pharmaceuticals Inc SNDX
Common Stock
|
2016-03-08 | Conversion | 718,396 | ||
|
Syndax Pharmaceuticals Inc SNDX
Series B-1 Preferred Stock · derivative
|
2016-03-08 | Conversion | 718,396 | ||
|
Syndax Pharmaceuticals Inc SNDX
Series A-1 Preferred Stock · derivative
|
2016-03-08 | Conversion | 1,138,210 | ||
|
Epizyme Inc EPZM
Common Stock
|
2014-02-10 | Sell | 466,666 | $29.25 | 13,649,980 |
|
Epizyme Inc EPZM
Common Stock
|
2013-06-05 | Conversion | 2,309,998 | ||
|
Epizyme Inc EPZM
Series A Preferred Stock · derivative
|
2013-06-05 | Conversion | 6,930,000 | ||
|
Epizyme Inc EPZM
Series B Preferred Stock · derivative
|
2013-06-05 | Conversion | 1,176,472 | ||
|
Epizyme Inc EPZM
Common Stock
|
2013-06-05 | Conversion | 392,156 |